A82 DELIVERY OF AMBULATORY CARE DURING THE COVID-19 PANDEMIC IN THE DIVISION OF DIGESTIVE CARE & ENDOSCOPY, HALIFAX, NS

por Francheville, J, Koto, P, Peltekian, K
Publicado 2022

A212 LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS (PSC): EXPERIENCE FROM THE LAST THREE DECADES

por Zhu, J, Lim, D R, James, L J, Yoshida, E M, Peltekian, K M
Publicado 2022

A102 INTERDISCIPLINARY TELEHEALTH REFERRAL PATHWAY AND CONSULTATIONS TO IMPROVE OUTCOMES AMONG CANADIAN OLDER ADULTS WITH LIVER CIRRHOSIS

por Zhu, J, Carr, F, Tian, P, McLeod, M, MacFarlane, M, De Coutere, S, Sun, M, Peltekian, K
Publicado 2023

Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and R...

por Marotta, P., Bailey, R., Elkashab, M., Farley, J., Feinman, S. V., Peltekian, K., Poliquin, M., Witt-Sullivan, H., Rampakakis, E., Drolet, M., Cooper, C.
Publicado 2016

Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3

por Powis, J, Peltekian, K M, Lee, S S, Sherman, M, Bain, V G, Cooper, C, Krajden, M, Deschenes, M, Balshaw, R F, Heathcote, E Jenny, Yoshida, E M
Publicado 2008